Shots:
- neurocare has received US FDA clearance for its Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices to treat major depressive disorder (MDD) in adolescents
- The Apollo TMS Therapy system is a non-invasive treatment that uses a magnetic coil on the head to stimulate targeted brain pathways, with about 60% of patients achieving remission with TMS
- The Apollo TMS Therapy previously received FDA clearance to treat MDD in adults unresponsive to oral antidepressants & as an adjunctive therapy for OCD in adults who have not responded to traditional treatments
Ref: neurocare | Image: neurocare| Press Release
Related News:- neurocare Receives the US FDA’s Clearance for Apollo TMS Therapy Devices to Treat Obsessive Compulsive Disorder
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
